Bank of America’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,300
Closed -$67K 7190
2017
Q4
$67K Buy
+3,300
New +$60.7K ﹤0.01% 5932
2015
Q1
Sell
-900
Closed -$9K 7259
2014
Q4
$9K Buy
900
+100
+13% +$889 ﹤0.01% 7099
2014
Q3
$7K Sell
800
-500
-38% -$4.76K ﹤0.01% 7451
2014
Q2
$13K Buy
1,300
+100
+8% +$848 ﹤0.01% 7359
2014
Q1
$15K Buy
1,200
+300
+33% +$4.45K ﹤0.01% 7042
2013
Q4
$13K Buy
+900
New +$11.6K ﹤0.01% 7196
2013
Q3
Sell
-3,000
Closed -$24K 7934
2013
Q2
$24K Buy
+3,000
New +$19.1K ﹤0.01% 6894

Other funds holding HALO

Bank of America's HALO Position: Q1 2026 in Review

Bank of America increased its Halozyme (HALO) stake by 6.6% in Q1 2026, buying an estimated $12.6M and bringing the position to 2,913,109 shares worth $188M. The position accounts for 0.01% of the portfolio, ranked #770.

Bank of America first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Bank of America held 2,913,109 shares of Halozyme worth $188M as of Q1 2026.
  • Bank of America bought 179,277 Halozyme shares in Q1 2026, an estimated $12.6M.
  • Halozyme made up 0.01% of Bank of America's portfolio in Q1 2026, its #770 holding.
  • Bank of America first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.